Hypoglycemia–if taken with sulphonylureas or insulin Thrush Urinary Tract Infections Increased urination Pain when urinating Changes in levels of blood fats Blood pressure lowering

In recent trials of SGLT2i treatments, mortality was reduce for all-cause and cardiovascular death in patients with heart failure with reduced ejection fraction and a reduction in hospital admissions. Kidney function also improved. These medications are now available for people with heart failure with reduced ejection fraction, with or without type 2 diabetes.

SGLT2i (Gliflozins) medication stands for Sodium-glucose co-transporter-2 and can lower the glucose (sugar) levels in the blood